Synthetic glycosylated ether glycerolipids as anticancer agents

RSC Drug Discovery Series

Volumn 2015-January, Issue 43, 2015, Pages 151-179

  Arthur, Gilbert ^a   Schweizer, Frank ^a   Ogunsina, Makanjuola ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE; AMINOSUGAR; ANTINEOPLASTIC AGENT; DISACCHARIDE; EDELFOSINE; ETHER GLYCEROLIPID; ETHER LIPID; GLYCEROL; GLYCOSIDASE; THIOGLYCOSIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BENZYLATION; CANCER STEM CELL; CELL DEATH; CELL VIABILITY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; GLYCOSYLATION; GUANIDINYLATION; HEMOLYSIS; HUMAN; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; THROMBOGENICITY;

EID: 84937426269     PISSN: 20413203     EISSN: 20413211     Source Type: Book Series    
DOI: None     Document Type: Article

References (83)

1. World Cancer Research Fund International; http://www.wcrf.org/cancer- statistics/world-cancer-statistics.php.
2. D. G. Kruh, Oncogene, 2003, 22, 7262.
3. L. Gatti and F. Zunino, Methods Mol. Med., 2005, 111, 127.
4. D. B. Longley and P. G. Johnston, J. Pathol., 2005, 205, 275.
5. J. Plati, O. Bucur and R. Khosrvi-Far, Integr. Biol., 2011, 3, 279.
6. Y. Dai, T. S. Lawrence and L. Xu, Am. J. Transl. Res., 2009, 1, 1.
7. J. A. Magee, E. Piskounovva and S. J. Morrison, Cancer Cell, 2012, 21, 283.
8. L. N. Abdullah and E. K.-H. Chow, Clin. Transl. Med., 2013, 2, 3.
9. L. Chang, P. H. Graham, J. Hao, J. Bucci, P. J. Cozzi, J. H. Kearsley and Y. Li, Cancer Metastasis Rev., 2014, 33, 469.
10. S. Fulda and S. Pervaiz, Int. J. Biochem. Cell Biol., 2009, 42, 31.
11. B. K. Garvalov and T. Acker, J. Mol. Med., 2011, 89, 95.
12. P. C. Hermann, S. L. Huber, T. Herrler, A. Aicher, J. W. Ellwart and M. Guba, Cell Stem Cell, 2007, 1, 313.
13. R. Zobalova, M. Stantic, M. Stapelberg, K. Prokopova, J. Dong, J. Truksa et al., in Drugs that Kill Cancer Stem-like Cells, ed. S. Shostak Cancer Stem Cells Theories and Practice, 2011, ISBN: 978-953-307-225-8.
14. P. Samadder, Y. Xu, F. Schweizer and G. Arthur, Eur. J. Med. Chem., 2014, 78, 225.
15. P. Samadder, R. Bittman, H.-S. Byun and G. Arthur, Biochem. Cell Biol., 2009, 87, 401.
16. L. Jahreiss, M. Renna, R. Bittman, G. Arthur and D. C. Rubinsztein, Autophagy, 2009, 5, 835.
17. R. Bittman and G. Arthur in Antitumor ether lipids: biological and biochemical effects in Liposomes: Rationale Design, ed. A. S. Janoff, Marcel Dekker, New York, 1999, pp. 125-144.
18. W. E. Berdel, R. Andreesen and P. G. Munder, in Phospholipids and Cellular Regulation, ed. J. F. Kuo, CRC Press, Boca Raton, FL, 1985, vol. 2, pp. 41-73.
19. W. E. Berdel, Br. J. Cancer, 1991, 64, 208.
20. W. E. Berdel, W. R. E. Bausert, U. Fink, J. Rastetter and P. G. Munder, Anticancer Res., 1981, 1, 345.
21. W. J. Houlihan, M. Lohmeyer, P. Workman and S. H. Cheon, Med. Res. Rev., 1995, 15, 157.
22. L. A. Smets, H. Van Rooij and G. S. Salmons, Apoptosis, 1999, 4, 419.
23. W. J. van Blitterswijk and M. Verheij, Biochim. Biophys. Acta, 2013, 1831, 663.
24. C. Gajate, A. Santos-Beneit, M. Modolell and F. Mollinedo, Mol. Pharmacol., 1998, 53, 602.
25. J. K. Jackson, H. M. Burt, A. M. Oktaba, W. Hunter, M. P. Scheid, F. Mouhajir, R. W. Lauemer, Y. Shen, H. Salari and V. Duronio, Cancer Chemother. Pharmacol., 1998, 41, 326.
26. F. Mollinedo, C. Gajate, S. Martin-Santamaria and F. Gago, Curr. Med. Chem., 2004, 11, 3163.
27. J. J. Gills and P. A. Dennis, Curr. Oncol. Rep., 2009, 11, 102.
28. H. Prinz, L. Six, K.-P. Ruess and M. Lieflander, Liebigs Ann. Chem., 1985, 217.
29. N. Weber and H. Benning, Chem. Phys. Lipids, 1986, 41, 93.
30. P. N. Guivisdalsky, R. Bittman, Z. Smith, M. L. Blank, F. Snyder, S. Howard and H. Salari, J. Med. Chem., 1990, 33, 2614.
31. A. Noseda, M. E. Berens, C. Piantadosi and E. J. Modest, Lipids, 1987, 22, 878.
32. D. B. J. Hermann, E. Besenfelder, U. Bicker, W. Pahlke and E. Bohm, Lipids, 1987, 22, 952.
33. X. Lu, K. Rengan, R. Bittman and G. Arthur, Oncol. Rep., 1994, 1, 933.
34. R. K. Erukulla, X. Zhou, P. Samadder, G. Arthur and R. Bittman, J. Med. Chem., 1996, 39, 1541.
35. K. C. Nicolaou, D. E. Lizos, D. W. Kim, D. Schlawe, R. G. de Noronha, D. A. Longbottom, M. Rodriquez, M. Bucci and G. Cirino, J. Am. Chem. Soc., 2006, 128, 4460.
36. P. Samadder, H.-S. Byun, R. Bittman and G. Arthur, Anticancer Res., 2011, 31, 3809.
37. A. M. Rogan, T. C. Hamilton, R. C. Young, R. W. Klecker Jr. and R. F. Ozols, Science, 1984, 224, 994.
38. J. A. Green, D. T. Vistica, R. C. Young, T. C. Hamilton, A. M. Rogan and R. F. Ozols, Cancer Res., 1984, 44, 5472.
39. Y. Xu, M. Ogunsina, P. Samadder, G. Arthur and F. Schweizer, Chem Med Chem, 2013, 8, 511.
40. E. A. M. Fleer, C. Unger, D.-J. Kim and H. Eibl, Lipids, 1987, 22, 856.
41. X. Lu, X. Zhou, D. Kardash and G. Arthur, Biochem. Cell Biol., 1993, 71, 122.
42. N. Weber and H. Benning, Biochim. Biophys. Acta, 1988, 959, 91.
43. G. Arthur and P. Samadder, Unpublished observation 2013.
44. M. Ogunsina, H. Pan, P. Samadder, G. Arthur and F. Schweizer, Molecules, 2013, 18, 15288.
45. G. Yang, R. W. Franck, R. Bittman, P. Samadder and G. Arthur, Org. Lett., 2001, 3, 197.
46. G. Yang, R. W. Franck, H.-S. Byun, R. Bittman, P. Samadder and G. Arthur, Org. Lett., 1999, 1, 2149.
47. A. Girault, J.-P. Haelters, M. Potier-Cartereau, A. Chantome, M. Pinault, S. Marionneau-Lambot, T. Oullier, G. Simon, H. Couthon-Gourves, P.-A. Jaffres, B. Corbel, P. Bougnoux, V. Joulin and C. Vandier, Curr. Cancer Drug Targets, 2011, 11, 1111.
48. J. R. Marino-Albernas, R. Bittman, A. Peters and E. Mayhew, J. Med. Chem., 1996, 39, 3241.
49. H. S. Byun, R. Bittman, P. Samadder and G. Arthur, Chem Med Chem, 2010, 5, 967.
50. R. Andreesen, M. Modolell, H. U. Weltzein, H. Eibl, H. H. Common, G. W. Lohr and P. G. Munder, Cancer Res., 1978, 38, 3894.
51. L. Glasser, L. R. Somberg and W. R. Vogler, Blood, 1984, 64, 1288.
52. R. Andreesen, M. Modolell and P. G. Munder, Blood, 1979, 54, 519.
53. M. H. Runge, R. Andreesen, A. Pfleiderer and P. G. Munder, J. Natl. Cancer Inst., 1980, 64, 1301.
54. F. Mollinedo, J. de la Iglesi-Vincente, C. Gajate, A. E.-H. de Mendoza, J. A. Villa-Pulgrin, M. de Frais, G. Roue, J. Gil, D. Colomer, M. A. Campanero and M. J. Blanco-Prieto, Clin. Cancer Res., 2010, 16, 2046.
55. J. Storch and P. G. Munder, Lipids, 1987, 22, 813.
56. G. Powis, M. J. Seewald, C. Gratas, D. Elder, J. Riebow and E. J. Modest, Cancer Res., 1992, 52, 2835.
57. I. Junghahn, J. Bergmann, P. Langen, I. Thun, C. Vollgraf and H. Brachwitz, Anticancer Res., 1995, 15, 449.
58. S. Egan, J. A. Wright, L. Jarolim, K. Yanagihara, R. H. Bassin and A. H. Greenberg, Science, 1987, 238, 202.
59. P. Samadder, H.-S. Byun, R. Bittman and G. Arthur, Anticancer Res., 1998, 18, 465.
60. N. Weber and H. Benning, in Topics in Lipid Research from Structural Elucidation to Biological Function, ed. R. Klein and B. Schmititz, Royal Soceity of Chemistry, London, 1986, pp. 14-19.
61. I. Ahmad, J. J. Filep, J. C. Franklin, A. S. Janoff, G. R. Masters, J. Pattassery, A. Peters, J. J. Schupsky, Y. Zha and E. Mayhew, Cancer Res., 1997, 57, 1915.
62. J. V. Busto, E. Del Canto-Jañez, F. M. Goñi, F. Mollinedo and A. Alonso, J. Chem. Biol., 2008, 1, 89.
63. J. K. Jackson, H. Burt, W. Mok, H. Salari, E. R. Kumar, H.-S. Byun and R. Bittman, Biochem. Cell Biol., 1994, 72, 297.
64. D. S. Vallari, Z. L. Smith and F. Snyder, Biochem. Biophys. Res. Commun., 1988, 156, 1.
65. S. A. Susin, N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens and G. Kroemer, J. Exp. Med., 1996, 184, 1331.
66. N. Mizushima, A. Yamamoto, M. Hatano, Y. Kobayashi, Y. Kabeya, K. Suzuki, T. Tokuhisa, Y. Ohsumi and T. Yoshimori, J. Cell Biol., 2001, 152, 657.
67. Y. Takahashi, D. Coppola, N. Mattsushita, H. D. Cualing, M. Sun, Y. Sato, C. Liang, J. U. Jung, J. Q. Cheng, J. J. Mule, W. J. Pledger and H. G. Wang, Nat. Cell Biol., 2007, 9, 1142.
68. E.-L. Punnonen, K. Ryhanen and V. Marjomaki, Eur. J. Cell Biol., 1998, 75, 344.
69. L. A. Casiola-Rosen and A. L. Hubbard, J. Biol. Chem., 1992, 267, 8213.
70. W. A. Dunn, A. L. Hubbard and N. A. Aronson, J. Biol. Chem., 1980, 255, 5971.
71. P. C. Sullivan, A. L. Ferris and B. Storrie, J. Cell. Physiol., 1987, 131, 58.
72. H. Appelqvist, A.-C. Johansson, E. Linderoth, U. Johansson, B. Antonsson, R. Steinfeld, K. Kagedal and K. Ollinger, Ann. Clin. Lab. Sci., 2012, 42, 231.
73. M. Al-Hajj, M. S. Wicha, I. Weissman and M. F. Clarke, Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 3983.
74. A. T. Collins, P. A. Berry, C. Hyde, M. Stower and N. J. Maitlan, Cancer Res., 2005, 65, 10946.
75. C. O'Brien, A. Pollet, S. Gallinger and J. E. Dick, Nature, 2007, 445, 106.
76. C. Li, D. G. Heidt, P. Dalerba, C. F. Burant, L. Zhang, V. Adsav, M. Wicha, M. F. Clarke and D. M. Simeone, Cancer Res., 2007, 67, 1030.
77. Y. Pan and X. Huang, Int. J. Clin. Exp. Med., 2008, 1, 260.
78. N. A. Lobo, Y. Shimono, D. Qian and M. F. Clarke, Annu. Rev. Cell Dev. Biol., 2007, 23, 41.
79. R. Besancon, S. Valsesia-Wittman, A. Puisieux, C. C. de Fromental and V. Maguer-Satta, Curr. Med. Chem., 2009, 16, 394.
80. N. Y. Frank, T. Schatton and M. H. Frank, J. Clin. Invest., 2010, 120, 41.
81. L. R. Ferguson and A. E. Pearson, Mutat. Res., 1996, 355, 1.
82. H.-S. Byun, R. Bittman, P. Samadder and G. Arthur, Chem Med Chem, 2010, 5, 1045.
83. N. Weber and H. Benning, J. Nutr., 1984, 114, 247.